Thomas Schmittgen D. PhD

Thomas Schmittgen D. PhD
ProfessorCollege of Pharmacyschmittgen.2@osu.edu
536 Parks Hall 500 W 12th Avenue Columbus Ohio 43210
Phone:614-292-3456Fax: (614) 292-7766
  • Molecular Biology and Cancer Genetics

Research Description

Dr. Schmittgen's research interests are Quantitative gene expression analysis and the role of small, noncoding (i.e. micro RNAs) in cancer.

Current Publications

  • Azevedo-Pouly AC, Elgamal OA, Schmittgen Thomas DRNA Isolation from Mouse Pancreas: A Ribonuclease-rich Tissue.J Vis Exp 1/1/2014
  • Collins AL, Wojcik S, Liu J, Frankel WL, Alder H, Yu L, Schmittgen TD, Croce CM, Bloomston MA differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.Ann Surg Oncol 21 133-8 1/1/2014
  • Schmittgen TDMicrobiomarkers with big impact in CLL.Blood 122 1843-4 9/12/2013
  • McNally ME, Collins A, Wojcik SE, Liu J, Henry JC, Jiang J, Schmittgen T, Bloomston MConcomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.HPB (Oxford) 15 260-4 4/1/2013
  • Elgamal OA, Park JK, Gusev Y, Azevedo-Pouly AC, Jiang J, Roopra A, Schmittgen TDTumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation.PLoS One 8 e76402 1/1/2013

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu